Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BECN1 | Q14457 | 3/20 | 0.53 |
| ▸ | TNFSF11 | O14788 | 1/20 | 0.53 |
| ▸ | KLK7 | P49862 | 1/20 | 0.53 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.51 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.51 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.51 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.51 |
| ▸ | KRAS | P01116 | 4/20 | 0.51 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.50 |
| ▸ | NPR1 | P16066 | 1/20 | 0.50 |
| ▸ | NPR3 | P17342 | 1/20 | 0.50 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.50 |
| ▸ | F12 | P00748 | 2/20 | 0.50 |
| ▸ | F10 | P00742 | 1/20 | 0.49 |
| ▸ | F11 | P03951 | 1/20 | 0.49 |
| ▸ | KLK1 | P06870 | 1/20 | 0.49 |
| ▸ | KLK2 | P20151 | 1/20 | 0.49 |
| ▸ | KLK14 | Q9P0G3 | 1/20 | 0.49 |
| ▸ | KLK13 | Q9UKR3 | 1/20 | 0.49 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29860724 | 0.93 | F12 (0.52) | BECN1TNFSF11KLK7KRASCXCR4 | |
| Protegrin 1 SCHEMBL29352276 | 0.92 | F12 (0.54) | BECN1KLK7KLKB1CXCR4F12 | |
| SCHEMBL29389051 | 0.92 | CTSG (0.51) | BECN1TNFSF11KRASKLKB1CXCR4 | |
| Iseganan SCHEMBL29378977 | 0.89 | CTSG (0.56) | BECN1TNFSF11CSNK2A2CSNK2BCSNK2A1 | |
| Iseganan SCHEMBL29420585 | 0.89 | CTSG (0.55) | BECN1TNFSF11CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL29385468 | 0.88 | KCNMA1 (0.57) | TNFSF11KLKB1F12RXFP4RXFP3 | |
| SCHEMBL29385556 | 0.88 | CXCR4 (0.60) | KRASKLKB1CXCR4F12 | |
| Hydrochloric Acid SCHEMBL27846143 | 0.85 | CTSG (0.54) | BECN1TNFSF11CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL29353475 | 0.77 | F12 (0.58) | TNFSF11KLKB1F12F11 | |
| SCHEMBL29509630 | 0.77 | F12 (0.58) | TNFSF11KLKB1F12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12377186-B2 | Antimicrobial biopolymer compositions, methods of synthesis, and applications of use | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-08-05 | — | — | US | claimed |
| US-20230270828-A1 | COMPOSITION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | BICT S.R.L. (IT) | 2023-08-31 | — | — | US | claimed |
| EP-3574909-B1 | POLYELECTROLYTE MULTILAYER COMPRISING SILVER FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20260000805-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12409247-B2 | Methods and compositions for wound healing | IMBED BIOSCIENCES INC. (US) | 2025-09-09 | — | — | US | disclosed |
| US-12377186-B2 | Antimicrobial biopolymer compositions, methods of synthesis, and applications of use | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250185669-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2025-06-12 | — | — | US | disclosed |
| US-12232498-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2025-02-25 | — | — | US | disclosed |
| US-12036267-B2 | Lactoferricin and lactoferrampin for treating infections | BICT S.R.L. (IT) | 2024-07-16 | — | — | US | disclosed |
| US-20240172762-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2024-05-30 | — | — | US | disclosed |
| US-11980192-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2024-05-14 | — | — | US | disclosed |
| US-20230270828-A1 | COMPOSITION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | BICT S.R.L. (IT) | 2023-08-31 | — | — | US | disclosed |
| US-20230270118-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2023-08-31 | — | — | US | disclosed |
| WO-2023141679-A1 | DIMERS AND USES THEREFOR | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (AU) | 2023-08-03 | — | — | WO | disclosed |
| EP-4188421-A1 | COMPOSITION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | BICT s.r.l. (IT) | 2023-06-07 | — | — | EP | disclosed |
| US-11554194-B2 | Methods and compositions for wound healing | IMBED BIOSCIENCES INC. (US) | 2023-01-17 | — | — | US | disclosed |
| EP-3995158-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | Imbed Biosciences, Inc. (US) | 2022-05-11 | — | — | EP | disclosed |
| US-11304420-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2022-04-19 | — | — | US | disclosed |
| US-20220087267-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2022-03-24 | — | — | US | disclosed |
| WO-2022029577-A1 | COMPOSITION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | BICT S.R.L. (IT) | 2022-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000805-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | PCNA, ARG1, PLOD3 | BECN1 1667/4885TNFSF11 714/4885KLK7 2922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.